Source: Annual Congress 2003 - PG6 - Molecular techniques in the diagnosis of lung disease - what clinicians need to know



Rating:

Share or cite this content

Citations should be made in the following way:
S. T. Holgate (Southampton, United Kingdom). Usefulness of pharmacogenetics. Annual Congress 2003 - PG6 - Molecular techniques in the diagnosis of lung disease - what clinicians need to know

Member's Comments

No comment yet.

Related content which might interest you: Usefulness in clinical practice Source: Annual Congress 2009 - Asthma control: monitoring tool or goal? Validity in children and adults Year: 2009 Usefulness in clinical studies in children Source: Annual Congress 2009 - Asthma control: monitoring tool or goal? Validity in children and adults Year: 2009 Therapeutic management - Current status and future developments Source: COVID-19 Videos Year: 2020 Advances in the diagnostic approach to sarcoidosis Source: Annual Congress 2013 –ERS/JAMA Lunchtime session "Advances in IPF, bronchiectasis and sarcoidosis" Year: 2013 Precision medicine in tuberculosis treatment – a role for pharmacogenetics? Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018 Non-invasive diagnostics: modern measures for screening and diagnosis Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 Contemporary diagnostics and staging Source: Annual Congress 2012 - PG10 An update on mesothelioma diagnostics and treatment Year: 2012 Usefulness of mannitol challenge testing for diagnosing asthma in everyday clinical practice Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Advances in the therapeutical management of IPF Source: Annual Congress 2012 - MS3 Update in idiopatic pulmonary fibrosis Year: 2012 Clinical implications – potential future developments in EBC research Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate Year: 2007 Physiologic rationale and clinical pitfalls Source: Virtual Congress 2021 – High flow nasal cannula in adults with acute respiratory failure Year: 2021 Therapeutic implications Source: Annual Congress 2009 - The lung cancer-COPD nexus Year: 2009 Clinical implications and novel therapies Source: International Congress 2018 – Accelerated ageing in lungs Year: 2018 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Impact of diagnostic pitfalls on the management of pulmonary sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021